Frontiers in HematOncology, Vol. 1, Issue 2
BloodLine is pleased to offer online access to this issue of Frontiers in HematOncology, a publication of BioScience Communications.
Frontiers in HematOncology seeks to provide timely reports on clinical and scientific developments in hematologic oncology. It features original articles, case studies, and news highlights from major scientific meetings.
The full issue of Vol. 1, Issue 2 can be downloaded from BloodLine in PDF format by clicking here.
Volume 1, Issue 2:
In this issue, Stephen B. Baylin and James G. Herman report on their new
understanding of epigenetic changes in carcinogenesis and the prospects
for therapeutic reactivation of epigenetically silenced genes. Catherine
M. Verfaillie and members of her stem cell research team describe their
trailblazing work with multipotent adult progenitor cells. And from
Salamanca, Spain, an unusual case report focuses on multiple allogeneic
PBSC transplantation in an acute myeloid leukemia patient. There is also
a report by Gareth Morgan on the Eighth International Conference on
Malignant Lymphoma in Lugano, Switzerland, together with extensive news
coverage from the recent meetings of the American Society of Clinical
Oncology (ASCO) in Orlando, Florida, and the European Hematology
Association (EHA) in Florence, Italy.
Download this issue of Frontiers in HematOncology
Copyright 1995-2010 - Carden Jennings Publishing Co., Ltd. All rights reserved. The material available at this site is for educational purposes only and is NOT intended for any diagnostic, clinically related, or other purpose. Carden Jennings Publishing Co., Ltd., assumes no responsibility for any use or misuse of this material and makes no warranty or representation of any kind with respect to the material available at this site.
|
|